Clinical trial
Rosuvastatin ORBITAL Germany
NCT00379249 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00379249 |
|---|---|
| Title | Rosuvastatin ORBITAL Germany |
| Official title | Effects of a Twelve Months ROSUVASTATIN Treatment Plus Additional Care (Drug Intake Adherence and Lifestyle Enhancing Initiatives ) Compared to ROSUVASTATIN Treatment Alone on Long-Term Disease-Related Costs in Patients With an Indication for Statin Treatment According to the Joint European… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin |
| Enrollment | 8,000 |
| Start date | Feb 1, 2002 |
| Completion | Feb 1, 2004 |
| First posted | Sep 21, 2006 |
| Last update posted | Mar 26, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: